BMEA Latest Headlines

JPMorgan’s top short ideas for Q1: FTNT, TXT, IMO and more

at seekingalpha.com (Fri, 23-Jan 11:24 AM)

Biomea Fusion Sets Sights on Key Diabetes and Obesity Milestones in 2026 Clinical Pipeline

Market Chameleon (Mon, 12-Jan 11:52 AM)

KOL Presentation Highlights Icovamenib’s Potential to Restore Beta Cell Function in Diabetes – A New Pathway for BMEA

Market Chameleon (Wed, 10-Dec 11:45 AM)